Diamant Asset Management Inc. Acquires 210,349 Shares of The Clorox Company $CLX

Diamant Asset Management Inc. grew its holdings in The Clorox Company (NYSE:CLX) by 8,753.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 212,752 shares of the company’s stock after buying an additional 210,349 shares during the quarter. Diamant Asset Management Inc.’s holdings in Clorox were worth $21,275,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP increased its holdings in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after purchasing an additional 7,465 shares in the last quarter. Baird Financial Group Inc. increased its holdings in shares of Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after purchasing an additional 424 shares in the last quarter. Jump Financial LLC raised its position in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after purchasing an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia raised its position in Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after purchasing an additional 3,352 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research report on Friday, May 1st. JPMorgan Chase & Co. dropped their target price on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. UBS Group decreased their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Insider Buying and Selling

In related news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Price Performance

Shares of CLX stock opened at $97.51 on Friday. The firm’s 50 day moving average price is $94.67 and its two-hundred day moving average price is $104.43. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The stock has a market cap of $11.79 billion, a PE ratio of 15.83, a PEG ratio of 0.51 and a beta of 0.56.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts forecast that The Clorox Company will post 5.61 EPS for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.